Koninklijke Philips (PHG) Income towards Parent Company (2009 - 2026)
Koninklijke Philips (PHG) posted quarterly Income towards Parent Company of $446.3 million for Q2 2026, up 64.3% year-over-year from $271.7 million in Q2 2025, and up 152.48% quarter-over-quarter from $176.8 million in Q1 2026.
Koninklijke Philips (PHG) Income towards Parent Company (2009 - 2026) Analysis & Trends
Koninklijke Philips' Income towards Parent Company history runs 18 years deep, the most recent figure standing at $446.3 million for Q2 2026.
- In Q2 2026, Income towards Parent Company rose 64.3% year-over-year to $446.3 million; the TTM figure through Jun 2026 stood at $1.7 billion (up 761.82% YoY), while the FY2025 annual figure was $1.0 billion, up 238.88% from the prior year.
- Income towards Parent Company for Q2 2026 stood at $446.3 million, up from $176.8 million in the prior quarter.
- The five-year high for Income towards Parent Company was $584.5 million in Q3 2025, with the low at -$1.6 billion in Q4 2022.
- The 5-year median for Income towards Parent Company is $79.2 million (2023), against an average of -$124.5 million.
- The sharpest annual moves came in 2022 and 2024: Income towards Parent Company plunged 351243413099.33% in 2022, then jumped 519.46% in 2024.
- Koninklijke Philips' Income towards Parent Company stood at -$1.6 billion in 2022, then soared by 69.44% to -$501.4 million in 2023, then grew by 28.82% to -$356.9 million in 2024, then jumped by 228.83% to $459.8 million in 2025, then decreased by 2.93% to $446.3 million in 2026.
- Business Quant data shows PHG's Income towards Parent Company at $446.3 million in Q2 2026, $176.8 million in Q1 2026, and $459.8 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.54 Bn | 193.94 Bn | 7.27 Bn |
| 2 | Stryker | 129.61 Bn | 126.14 Bn | 4.50 Bn |
| 3 | Medtronic | 120.10 Bn | 110.88 Bn | 6.41 Bn |
| 4 | Boston Scientific | 74.14 Bn | 73.60 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 52.52 Bn | 48.27 Bn | 1.35 Bn |
| 6 | Dexcom | 34.69 Bn | 32.75 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.78 Bn | 31.68 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.42 Bn | 23.10 Bn | 4.55 Bn |
| 9 | Steris | 23.09 Bn | 22.61 Bn | 684.20 Mn |
| 10 | Zimmer Biomet Holdings | 19.37 Bn | 18.96 Bn | 1.54 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 446.35 Mn |
| Mar 31, 2026 | 176.78 Mn |
| Dec 31, 2025 | 459.80 Mn |
| Sep 30, 2025 | 584.53 Mn |
| Jun 30, 2025 | 271.67 Mn |
| Mar 31, 2025 | 79.94 Mn |
| Dec 31, 2024 | -356.91 Mn |
| Sep 30, 2024 | 198.78 Mn |
| Jun 30, 2024 | 485.68 Mn |
| Mar 31, 2024 | -1.09 Bn |
| Dec 31, 2023 | -501.39 Mn |
| Sep 30, 2023 | 95.80 Mn |
| Jun 30, 2023 | 78.40 Mn |
| Mar 31, 2023 | -0.75 |
| Dec 31, 2022 | -1.64 Bn |
| Sep 30, 2022 | -1.34 Bn |
| Jun 30, 2022 | -23.48 Mn |
| Mar 31, 2022 | -169.47 Mn |
| Dec 31, 2021 | 3.80 Bn |
| Sep 30, 2021 | 512.99 Mn |